Pliant Book Value Per Share from 2010 to 2025

PLRX Stock

USD 1.46 0.03 2.01%

Pliant Therapeutics Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 3.82 in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Pliant Therapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

5.02292428

Current Value

3.82

Quarterly Volatility

2.26760146

Credit Downgrade

Yuan Drop

Covid

Check Pliant Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pliant Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 22.1 M, Net Interest Income of 19 M or Interest Income of 22.1 M, as well as many indicators such as Price To Sales Ratio of 636, Dividend Yield of 0.0 or PTB Ratio of 2.75. Pliant financial statements analysis is a perfect complement when working with Pliant Therapeutics Valuation or Volatility modules.

Check out the analysis of Pliant Therapeutics Correlation against competitors.

For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.

Latest Pliant Therapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Pliant Therapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Pliant Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pliant Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 5.00 X

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Pliant Book Value Per Share Regression Statistics

	Arithmetic Mean	4.46
	Geometric Mean	2.55
	Coefficient Of Variation	50.87
	Mean Deviation	1.47
	Median	4.19
	Standard Deviation	2.27
	Sample Variance	5.14
	Range	8.1185
	R-Value	0.27
	Mean Square Error	5.09
	R-Squared	0.08
	Significance	0.30
	Slope	0.13
	Total Sum of Squares	77.13

Pliant Book Value Per Share History

	2025	3.82
	2024	5.02
	2023	8.07
	2022	7.46
	2021	5.55
	2020	7.96
	2019	-0.0122

Other Fundumenentals of Pliant Therapeutics

Tangible Book Value Per Share

Pliant Therapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Debt	Deferred Long Term Liab	Net Invested Capital	Capital Stock	Net Working Capital	Capital Surpluse	Short Term Debt	Long Term Debt	Long Term Debt Total
Total Assets		0.98	0.92	-0.83	0.74	0.55	0.47	1.0	0.95	0.59	0.61	0.88	0.98	-0.92	0.99	0.84	-0.58	0.45	-0.36
Total Stockholder Equity	0.98		0.93	-0.78	0.7	0.48	0.28	0.98	0.94	0.55	0.68	0.82	1.0	-0.93	0.99	0.8	-0.53	0.38	-0.31
Net Tangible Assets	0.92	0.93		-0.88	0.69	0.49	0.3	0.91	0.91	0.6	0.77	0.78	0.95	-0.98	0.92	0.79	-0.59	0.55	-0.58
Retained Earnings	-0.83	-0.78	-0.88		-0.84	-0.32	-0.52	-0.82	-0.89	-0.5	-0.59	-0.66	-0.81	0.8	-0.83	-0.88	0.82	-0.77	0.77
Accounts Payable	0.74	0.7	0.69	-0.84		0.2	0.46	0.73	0.83	0.49	0.39	0.57	0.72	-0.66	0.72	0.78	-0.83	0.78	-0.5
Net Receivables	0.55	0.48	0.49	-0.32	0.2		0.53	0.56	0.36	0.38	-0.01	0.75	0.49	-0.51	0.52	0.19	-0.23	0.19	-0.21
Total Liab	0.47	0.28	0.3	-0.52	0.46	0.53		0.45	0.42	0.4	-0.06	0.61	0.3	-0.27	0.37	0.46	-0.4	0.51	-0.38
Total Current Assets	1.0	0.98	0.91	-0.82	0.73	0.56	0.45		0.94	0.58	0.61	0.87	0.98	-0.91	0.99	0.82	-0.56	0.42	-0.35
Common Stock	0.95	0.94	0.91	-0.89	0.83	0.36	0.42	0.94		0.51	0.7	0.8	0.94	-0.88	0.94	0.95	-0.62	0.63	-0.42
Property Plant Equipment	0.59	0.55	0.6	-0.5	0.49	0.38	0.4	0.58	0.51		0.42	0.71	0.59	-0.72	0.52	0.31	-0.25	0.24	-0.27
Net Debt	0.61	0.68	0.77	-0.59	0.39	-0.01	-0.06	0.61	0.7	0.42		0.43	0.7	-0.77	0.62	0.67	-0.13	0.33	-0.32
Deferred Long Term Liab	0.88	0.82	0.78	-0.66	0.57	0.75	0.61	0.87	0.8	0.71	0.43		0.83	-0.83	0.83	0.65	-0.36	0.4	-0.25
Net Invested Capital	0.98	1.0	0.95	-0.81	0.72	0.49	0.3	0.98	0.94	0.59	0.7	0.83		-0.96	0.99	0.81	-0.55	0.42	-0.36
Capital Stock	-0.92	-0.93	-0.98	0.8	-0.66	-0.51	-0.27	-0.91	-0.88	-0.72	-0.77	-0.83	-0.96		-0.91	-0.71	0.49	-0.45	0.46
Net Working Capital	0.99	0.99	0.92	-0.83	0.72	0.52	0.37	0.99	0.94	0.52	0.62	0.83	0.99	-0.91		0.83	-0.6	0.42	-0.37
Capital Surpluse	0.84	0.8	0.79	-0.88	0.78	0.19	0.46	0.82	0.95	0.31	0.67	0.65	0.81	-0.71	0.83		-0.61	0.69	-0.46
Short Term Debt	-0.58	-0.53	-0.59	0.82	-0.83	-0.23	-0.4	-0.56	-0.62	-0.25	-0.13	-0.36	-0.55	0.49	-0.6	-0.61		-0.72	0.75
Long Term Debt	0.45	0.38	0.55	-0.77	0.78	0.19	0.51	0.42	0.63	0.24	0.33	0.4	0.42	-0.45	0.42	0.69	-0.72		-0.73
Long Term Debt Total	-0.36	-0.31	-0.58	0.77	-0.5	-0.21	-0.38	-0.35	-0.42	-0.27	-0.32	-0.25	-0.36	0.46	-0.37	-0.46	0.75	-0.73

Click cells to compare fundamentals

About Pliant Therapeutics Financial Statements

Pliant Therapeutics investors use historical fundamental indicators, such as Pliant Therapeutics' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pliant Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	5.02	3.82
Tangible Book Value Per Share	5.02	3.82

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC